Carbon-Encapsulated Magnetite Nanodoughnut as a NIR-II Responsive Nanozyme for Synergistic Chemodynamic-Photothermal Therapy

Adv Healthc Mater. 2023 Nov;12(29):e2301926. doi: 10.1002/adhm.202301926. Epub 2023 Aug 13.

Abstract

Magnetite-based nanozymes have attracted great interest for catalytic cancer therapy enabled by catalyzing hydrogen peroxide (H2 O2 ) to produce highly toxic hydroxyl radicals (•OH) to kill tumor cells. However, their therapeutic efficacies remain low due to insufficient •OH. Here, a light-responsive carbon-encapsulated magnetite nanodoughnuts (CEMNDs) with dual-catalytic activities for photothermal-enhanced chemodynamic therapy (CDT) is reported. The CEMNDs can accumulate in tumor and get into tumor cells and effectively act as peroxidase to convert H2 O2 to •OH that causes tumor cell death. The CEMNDs also possess intrinsic glutathione oxidase-like activity that which catalyzes the oxidation of reduced glutathione and produce lipid peroxidase for enhanced catalytic therapy. Furthermore, the CEMNDs can absorb 1064 nm light to elevate local temperature and increase release of Fe ions for photothermal therapy and enhanced CDT respectively. The in vivo experiments in an aggressive and drug-resistant metastatic mouse model of triple negative breast cancer model demonstrate excellent synergistic anti-tumor function and no measurable systemic toxicity of CEMNDs.

Keywords: chemodynamic therapy; doughnut-like structures; magnetite nanozymes; photothermal therapy; synergistic effects.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carbon
  • Cell Line, Tumor
  • Ferrosoferric Oxide*
  • Glutathione
  • Hydrogen Peroxide
  • Mice
  • Neoplasms*
  • Peroxidase
  • Peroxidases
  • Photothermal Therapy
  • Tumor Microenvironment

Substances

  • Ferrosoferric Oxide
  • Peroxidase
  • Peroxidases
  • Carbon
  • Hydrogen Peroxide
  • Glutathione